Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen drug gets priority review for bone cancer
Amgen drug gets priority review for bone cancer
Amgen drug gets priority review for bone cancer
Submitted by
admin
on July 18, 2010 - 7:46am
Source:
Marketwatch
News Tags:
bone cancer
Amgen
FDA
denosumab
Prolia
Headline:
Amgen drug gets priority review for bone cancer
Do Not Allow Advertisers to Use My Personal information
